glp 1 news Alarming rise in weight loss drug overdoses GLP-1 receptor agonists show promise

There were no significant differences in dietary intake based on participants ethnicity, GLP-1RA usage duration, and education

And as the buzz on these medications, especially semaglutide, grows louder, people are flocking to doctors or the black market to get their hands on them, even people who dont have obesity or diabetes

Theyve been around for decades, helping treat patients with type 2 diabetes and short bowel syndrome, but when it was discovered that they could also help patients with obesity, they became several household names Ozempic, Wegovy, Mounjaro, etc

They are often your family member, your neighbor, your work colleague or even your healthcare provider, Rothberg says

E., Lavell, J., and Foreman, R

Background GLP-1 agonists continue to strain plan sponsor budgets due to soaring utilization rates